CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
119 hedge funds and large institutions have $3.07B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 25 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $4.41B → $3.07B (-$1.33B)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
119
Holding in Top 10
4
Calls
$13.5M
Puts
$12.8M
Top Buyers
| 1 | +$42.6M | |
| 2 | +$20.9M | |
| 3 | +$16.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.5M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$15.3M |
Top Sellers
| 1 | -$38.6M | |
| 2 | -$22.2M | |
| 3 | -$20.9M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$19.6M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$18.5M |